SCHEMBL17802429

SCHEMBL17802429

O=C(O)c1ccc2ncc3c[nH]nc3c2n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
KDM4E B2RXH2 7/20 0.37
KMT2A Q03164 3/20 0.37
MGAM O43451 1/20 0.37
TDP1 Q9NUW8 2/20 0.35
TSHR P16473 1/20 0.35
ACMSD Q8TDX5 1/20 0.35
P4HTM Q9NXG6 3/20 0.35
P4HA1 P13674 1/20 0.35
MIF P14174 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.34
MEN1 O00255 2/20 0.34
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34
RAB9A P51151 1/20 0.34
MAPK1 P28482 1/20 0.33
ECE1 P42892 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17802430 0.73 ALOX15 (0.39) ALOX15ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL17608657 0.72 MGAM (0.48) ALOX15ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL17443543 0.69 KDM4E (0.41) ALOX15ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL4900470 0.69 KDM4E (0.47) ALOX15ALDH1A1KDM4ETDP1TSHR
SCHEMBL2022194 0.68 KDM4E (0.49) ALOX15ALDH1A1KDM4EKMT2AMGAM
SCHEMBL13313392 0.66 KDM4E (0.46) ALOX15ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL5254858 0.66 KDM4E (0.41) ALOX15ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL2175934 0.66 MGAM (0.64) ALOX15ALDH1A1HPGDHSD17B10KDM4E
SCHEMBL698486 0.65 MGAM (0.42) KDM4EMGAMTDP1
SCHEMBL1088781 0.64 KDM4E (0.67) ALOX15KDM4EKMT2AMGAMTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3226862-A1 ORGANIC COMPOUNDS Intra-Cellular Therapies, Inc. (US) 2017-10-11 EP disclosed
WO-2016090382-A1 ORGANIC COMPOUNDS INTRA-CELLULAR THERAPIES, INC. (US) 2016-06-09 WO disclosed